The global hernia mesh devices market is estimated to grow at a CAGR of 2.0%, from 2015 to 2020, to reach a market size of USD 3.73 Billion by 2020. Rising awareness levels, increasing aging population, and sedentary lifestyle are the major factors influencing the growth of the market.

Browse 210 market data Tables and 181 Figures spread through 233 Pages and in-depth TOC on "Hernia Mesh Devices Market

http://www.marketsandmarkets.com/Market-Reports/hernia-mesh-devices-market-203245450.html

Early buyers will receive 10% customization on reports.
The market is comprehensively analyzed at a granular level by geography to provide in-depth information on regional level and country level. The regions covered include Americas, which covers the U.S., Canada, Mexico, Brazil, Argentina, Chile, Colombia, Uruguay, Paraguay; Europe, which covers Germany, France, Italy, the U.K., Spain, Russia, Turkey, Denmark, Belgium, Switzerland, and the Netherlands; Asia-Pacific, which covers Japan, China, India, South Korea, Australia, Thailand, Singapore, Malaysia, Taiwan, Indonesia, New Zealand; and Middle East & Africa (MEA), which covers Egypt, Saudi Arabia, UAE, Israel, Oman, Kuwait, Zimbabwe, Kenya, Jordan, Algeria, Morocco, Libya, Tunisia, Sudan, Mauritius, and South Africa.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=203245450
The research report categorizes the global hernia mesh devices market by two segments based on product type and geography. Based on product (product material type), it is segmented into biological mesh and synthetic mesh.

For Customization on this report @ http://www.marketsandmarkets.com/requestCustomization.asp?id=203245450
Since APAC has a large population, it benefits in terms of a huge patient pool. In 2014, around 62% of total number of hernia repair procedures performed worldwide were in APAC, which shows huge potential of this region.

Some of the major players in the hernia mesh market globally include Medtronic (U.S.), Ethicon, Inc. (U.S.), C.R. Bard, Inc. (U.S.), Atrium (Sweden), W.L. Gore & Associates (Germany), LifeCell Corporation (U.S.), and B. Braun Melsungen AG (Germany), among others.